healthcare AI - Page 20

NVIDIA joined the European Commission's AI in Science Enablers initiative at the Dublin summit, pledging tools, compute and training for researchers.

Deep Origin says its AI found drug hits against a new BioAge Labs target that BioAge has confirmed in the lab, in a new multi-target collaboration.

Google DeepMind and Google Cloud will give up to 200 European researchers frontier-model access and $3M in compute credits via the EU's RAISE scheme.

South African lab Ampath confirms a cybersecurity incident that may have exposed patient data. Attacker ByteToBreach claims over 80 million records.

Zealand Pharma will pay Generate Biomedicines $30M upfront to design AI-engineered protein drugs for obesity, with milestones worth nearly $1.2 billion.

Albert, which makes AI software for chemistry labs, raised a $55 million Series B led by TCV. Its 45x accuracy claim for its model is its own.

Seqera has launched Nextflow Frontier, an AI system that runs thousands of biology experiments. Its benchmark results are Seqera's own claims.

DeepMind's AlphaProof Nexus is in Science. Its authors report 9 of 353 Erdős problems and 44 of 492 OEIS conjectures proved. What that means, and the limits.

The White House says eleven companies pledged $2.4 billion in AI tools and compute credits to the Genesis Mission Consortium, led by Nvidia ($1bn), AMD ($500m) and OpenAI ($200m). Who pledged what, what the companies themselves say, and why a pledge is not spend.

Three AI business items from 8–9 October 2026: Nvidia-backed Firmus withdraws its ASX listing and turns to private money; Bloomberg reports Isomorphic Labs is in early funding talks at a valuation of at least $40 billion; and StepFun's Step 5 Preview model is now listed on OpenRouter and Vercel's AI Gateway. What is confirmed, and what is only reported.